We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLXS icon
3726
Plexus
PLXS
$7.16B
– –
-3,653
Closed -$350K
PMT
3727
PennyMac Mortgage Investment
PMT
$818M
– –
-47,529
Closed -$824K
PMVP icon
3728
PMV Pharmaceuticals
PMVP
$65.6M
– –
-66,743
Closed -$1.54M
PRGS icon
3729
Progress Software
PRGS
$1.78B
– –
-40,726
Closed -$1.97M
PRLD icon
3730
Prelude Therapeutics
PRLD
$385M
– –
-116,303
Closed -$1.45M
QFIN icon
3731
Qfin Holdings
QFIN
$1.59B
– –
-5,732
Closed -$131K
QQQ icon
3732
Invesco QQQ Trust
QQQ
$479B
– –
-800
Closed -$318K
RAPT
3733
DELISTED
RAPT Therapeutics
RAPT
– –
-1,117
Closed -$328K
RBA icon
3734
RB Global
RBA
$17.4B
– –
-162,947
Closed -$9.97M
REG icon
3735
Regency Centers
REG
$13.9B
– –
-40,172
Closed -$3.03M
RENT
3736
Rent the Runway
RENT
$122M
– –
-2,211
Closed -$360K
RFL icon
3737
Rafael Holdings
RFL
$103M
– –
-26,276
Closed -$132K
RGS icon
3738
Regis Corp
RGS
$70.8M
– –
-6,714
Closed -$234K
RNAM
3739
DELISTED
Avidity Biosciences
RNAM
– –
-11,401
Closed -$271K
RPID icon
3740
Rapid Micro Biosystems
RPID
$85.2M
– –
-12,684
Closed -$135K
RPTX
3741
DELISTED
Repare Therapeutics
RPTX
– –
-29,943
Closed -$631K
RYTM icon
3742
Rhythm Pharmaceuticals
RYTM
$7.95B
– –
-14,661
Closed -$146K
SABS icon
3743
SAB Biotherapeutics
SABS
$344M
– –
-1,290
Closed -$101K
FLNA
3744
Filana Therapeutics
FLNA
$48.2M
– –
-918
Closed -$40K
SENS icon
3745
Senseonics Holdings Inc
SENS
$394M
– –
-1,019
Closed -$54K
SHEN icon
3746
Shenandoah Telecom
SHEN
$737M
– –
-69,371
Closed -$1.77M
SIFY
3747
Sify Technologies
SIFY
$1.13B
– –
-1,932
Closed -$37K
SIGA icon
3748
SIGA Technologies
SIGA
$210M
– –
-29,276
Closed -$220K
HTO
3749
H2O America
HTO
$2.56B
– –
-38,264
Closed -$2.8M
SLDB icon
3750
Solid Biosciences
SLDB
$918M
– –
-1,248
Closed -$33K
148 149
150
151 152

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.